Bufalino Andreia, Cervigne Nilva K, de Oliveira Carine Ervolino, Fonseca Felipe Paiva, Rodrigues Priscila Campioni, Macedo Carolina Carneiro Soares, Sobral Lays Martin, Miguel Marcia Costa, Lopes Marcio Ajudarte, Paes Leme Adriana Franco, Lambert Daniel W, Salo Tuula A, Kowalski Luiz Paulo, Graner Edgard, Coletta Ricardo D
Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba-SP, Brazil.
Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba-SP, Brazil; Department of Dentistry, Federal University of Rio Grande do Norte, Natal-RN, Brazil.
PLoS One. 2015 Aug 28;10(8):e0136599. doi: 10.1371/journal.pone.0136599. eCollection 2015.
Deregulated expression of activin A is reported in several tumors, but its biological functions in oral squamous cell carcinoma (OSCC) are unknown. Here, we investigate whether activin A can play a causal role in OSCCs. Activin A expression was assessed by qPCR and immunohistochemistry in OSCC tissues. Low activin A-expressing cells were treated with recombinant activin A and assessed for apoptosis, proliferation, adhesion, migration, invasion and epithelial-mesenchymal transition (EMT). Those phenotypes were also evaluated in high activin A-expressing cells treated with follistatin (an activin A antagonist) or stably expressing shRNA targeting activin A. Transfections of microRNA mimics were performed to determine whether the overexpression of activin A is regulated by miR-143/miR-145 cluster. Activin A was overexpressed in OSCCs in comparison with normal oral mucosa, and high activin A levels were significantly associated with lymph node metastasis, tumor differentiation and poor survival. High activin A levels promoted multiple properties associated with malignant transformation, including decreased apoptosis and increased proliferation, migration, invasion and EMT. Both miR-143 and miR-145 were markedly downregulated in OSCC cell lines and in clinical specimens, and inversely correlated to activin A levels. Forced expression of miR-143 and miR-145 in OSCC cells significantly decreased the expression of activin A. Overexpression of activin A in OSCCs, which is controlled by downregulation of miR-143/miR-145 cluster, regulates apoptosis, proliferation and invasiveness, and it is clinically correlated with lymph node metastasis and poor survival.
据报道,激活素A在多种肿瘤中表达失调,但其在口腔鳞状细胞癌(OSCC)中的生物学功能尚不清楚。在此,我们研究激活素A是否在OSCC中起因果作用。通过qPCR和免疫组织化学评估OSCC组织中激活素A的表达。用重组激活素A处理低表达激活素A的细胞,并评估其凋亡、增殖、黏附、迁移、侵袭和上皮-间质转化(EMT)情况。在用卵泡抑素(一种激活素A拮抗剂)处理或稳定表达靶向激活素A的shRNA的高表达激活素A的细胞中也评估了这些表型。进行微小RNA模拟物转染以确定激活素A的过表达是否受miR-143/miR-145簇调控。与正常口腔黏膜相比,激活素A在OSCC中过表达,高激活素A水平与淋巴结转移、肿瘤分化及不良预后显著相关。高激活素A水平促进了与恶性转化相关的多种特性,包括凋亡减少以及增殖、迁移、侵袭和EMT增加。miR-143和miR-145在OSCC细胞系和临床标本中均明显下调,且与激活素A水平呈负相关。在OSCC细胞中强制表达miR-143和miR-145可显著降低激活素A的表达。OSCC中激活素A的过表达受miR-143/miR-145簇下调的控制,调节凋亡、增殖和侵袭性,且在临床上与淋巴结转移和不良预后相关。